PERDOCEO EDUCATION Corp (PRDO) · Nov 5, 2026 · Earnings

Perdoceo earnings beat as enrollment grows, but core growth stays modest

Beat — EPS $0.70 vs ~$0.69 consensus; revenue $215.9M vs ~$211.1M consensus

Perdoceo’s Q3 earnings beat consensus, helped by stronger operating income and cash flow, while enrollment and revenue growth remained measured.

Perdoceo is a postsecondary education operator rebuilding growth around its online institutions and its higher-growth health-sciences platform, with South University set to extend that strategy. The South deal was already announced on September 14, 2026, so the new information here is execution in the existing business rather than a fresh strategic pivot.

The quarter cleared the published bar, but only narrowly. Diluted EPS of $0.70 was modestly above the roughly $0.69 consensus, while revenue of $215.9 million topped the roughly $211.1 million expectation. The filing itself says, “Third quarter operating performance was ahead of our expectations,” and reports adjusted EPS of $0.77 versus $0.65 a year earlier. 〔0〕

Q3 2026Q3 2025Consensus
Revenue (Revenue)$215.9M (+1.9%)$211.9M$211.1M
Diluted EPS (Net income)$0.70 (+16.7%)$0.60~$0.69
Adjusted EPS (Non-GAAP reconciliation)$0.77 (+18.5%)$0.65
Operating income (Operating income)$55.1M (+8.1%)$51.0M
Operating cash flow (Cash Flow statement)$79.7M (+93.4%)$41.2M

Profit growth is running ahead of topline growth. Revenue rose only 1.9%, but operating income grew 8.1% and adjusted operating income 8.4%, helped by lower operating-expense intensity and continued contribution from USAHS. USAHS revenue increased 9.8% and operating income reached $4.6 million, while CTU revenue was nearly flat and CTU operating income fell 6.1%.

Enrollment is improving, but the mix remains uneven. Total enrollment rose 1.6% to 47,260, driven by AIUS and USAHS, while CTU declined 0.5%. That supports the company’s broader shift toward health sciences, but it does not yet show broad-based acceleration across the portfolio.

The balance sheet gives Perdoceo room to fund its next growth step. Year-to-date operating cash flow reached $223.8 million, and cash, restricted cash and short-term investments totaled $776.9 million. That makes the previously announced South University purchase—funded from available cash—financially feasible without new borrowing, though the acquisition remains a future execution event rather than a current earnings contribution.

The outlook is constructive but not a fresh upside reset. Management provided full-year 2026 adjusted EPS guidance of $3.15-$3.19 versus $2.61 in 2025, alongside adjusted operating income guidance of $260.0-$263.0 million. Because the filing does not provide a prior-company forecast to compare against, the cleanest read is that the company remains on track after the quarterly beat, not that it materially raised expectations.

Bottom line: Perdoceo delivered a genuine but modest earnings beat, with better margins and cash generation doing more work than revenue growth. The business is progressing toward a health-sciences-led expansion, but this quarter strengthens the existing story rather than rewriting it.

What to watch next

South University acquisition closing, as early as April 2027

Original filing on SEC EDGAR

More PERDOCEO EDUCATION Corp news

Perdoceo earnings beat as enrollment grows, but core growth stays modest | PRDO Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.